Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Clinical Trial, to Assess the Efficacy, Safety and Tolerability of Ciclesonide 200 Mcg Once Daily, Applied as a Nasal Spray for Four Weeks, in the Treatment of Intermittent and Persistent Rhinitis

NCT01369563 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01369563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01369563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Clinical Trial, to Assess the Efficacy, Safety and Tolerability of Ciclesonide 200 Mcg Once Daily, Applied as a Nasal Spray for Four Weeks, in the Treatment of Intermittent and Persistent Rhinitis
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
May 31, 2012
Enrollment
1,630 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perennial rhinitis, seasonal rhinitis